Adamas Pharmaceuticals
ADMS
#7201
Rank
S$0.49 B
Marketcap
$10.80
Share price
0.00%
Change (1 day)
15,770.66%
Change (1 year)

Earnings for Adamas Pharmaceuticals (ADMS)

Earnings in 2021 (TTM): -S$51.74 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current earnings are S$88.18 Million. In 2020 the company made an earning of -S$57.65 Million, an increase over its 2019 earnings that were of -S$0.12 Billion.

Earnings history for Adamas Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-S$51.74 Million-10.25%
2020-S$57.65 Million-51.34%
2019-S$0.12 Billion-19.45%
2018-S$0.15 Billion28.96%
2017-S$0.12 Billion42.3%
2016-S$80.14 Million6.18%
2015-S$75.48 Million-410.24%
2014S$24.32 M-67.53%
2013S$74.92 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.28 Billion 448.89%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.12 B-353.36%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.88 B-9,719.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.77 B-11,476.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$27.86 B-54,999.17%๐Ÿ‡บ๐Ÿ‡ธ USA